Antibody testing as a diagnostic tool in autonomic disorders

Area of Science:

• Neurology
• Immunology
• Oncology

Background:

• Peripheral autonomic dysfunction, including enteric neuropathy and subacute panautonomic failure, can manifest as autoimmune phenomena.
• These conditions may occur independently or be associated with cancer.
• Autoimmune autonomic ganglionopathy represents a severe, yet treatable, antibody-mediated autonomic failure.

Purpose of the Study:

• To highlight the role of autoimmune processes in peripheral autonomic dysfunction.
• To emphasize the diagnostic utility of antibody testing in autonomic disorders.
• To identify key antibodies associated with autoimmune autonomic failure.

Main Methods:

• Review of clinical presentations of autoimmune autonomic dysfunction.
• Discussion of diagnostic strategies for autonomic disorders.
• Identification of specific autoantibodies relevant to dysautonomia.

Main Results:

• Autoimmune phenomena are implicated in various forms of peripheral autonomic dysfunction.
• Autoimmune autonomic ganglionopathy is a significant antibody-mediated autonomic failure.
• Paraneoplastic antibodies (anti-Hu, CRMP-5) and ganglionic acetylcholine receptor antibodies are key diagnostic markers.

Conclusions:

• Autoimmune autonomic dysfunction is a critical consideration in patients presenting with autonomic failure.
• Antibody testing, including for paraneoplastic and ganglionic acetylcholine receptor antibodies, is crucial for diagnosis.
• Early diagnosis and identification of specific antibodies can lead to effective treatment strategies.